SIN_1015212 |
9 |
+
ATGGATGACGCCAGTGCAGTCTCTACTCCGCCACCAACCACCAGCACCGT
GGAAGGTGGTGGCGTTGGTACAGCCCCCGTCTTAACCACTGTCAATGGGC
CCGAATTGCCTAAACCGGAGGCTAATCACGTCAATGGGATCAAGGAAGAG
GCCGAGGCCGCTGCTTCTGAAGAGCTTTCCTCCGAAGATACCTCCGTCTA
TGGTACCCCACAAGCTCCGGACGCCGACCAAATTTCCCCAAATCTTCCCC
CGGAAACAGATGGGGACGAAGAAGAAGAAGGGGAAGAAGAGCGCCCTCCG
AAGAAGCAAAAGCAGCTCTCCGACTTGCCGAAAACGGAACCTGACGAACC
TGGAATGACCGAATTGCCCTCCCCTGCCAACGCAATTGCTGATTTATCCC
AGAATGGAAAGGCCCCCGCGACGAAATCAAGCAAGAAATCGAAGAAGAAG
AACAAAGATGTGTGGACTACCACGTCCAGGAAGGGAAAGAAAAAGACAAA
GCACGCCTCCAACAACAATCATAATTCCAAGAATGCCACCAACGGCGATA
CTGACGATAAAGTGTTTGTTTCCCCAGTTCCCAGATTTCCGGACAAAAAC
GACGACAGCCCGGACCTAAAAATCTGCCTCTCAAAGGCTTACAAGGCGGA
AAAGGTCGAATTGAGCGATGATAGACTGACTGCAGGCAGCTCAAAGGGTT
ATAGAATGGTGAGAGCAACTCGAGGAGTCACCGAGGGTGCTTGGTATTTC
GAGATTAAAGTGGTGCATTTGGGTGAAACGGGACATACAAGGCTGGGCTG
GTCAACTGATAAAGGTGACTTGCAAGCGCCCGTAGGATATGATGCGAATA
GTTTCGGGTATAGGGATATTGATGGGAGTAAGGTGCACAAAGCATTGAGG
GAAAAGTATGGGGAGGAAGGGTACAAAGAAGGTGATGTTATTGGGTTTTA
CATTAATTTGCCGGATGGAGGGTCTTATGCCCCTGATCCTCCGCGCTTGG
TTTGGTATAAAGGGCAGCGGTATGTTTGTGCTCCAGATGCCAGGGAGGAT
CCCGCGAAAGTTGTGCCTGGAAGTGAGATATCATTCTTCAGAAACGGAAT
ATGCCAGGGGGTTGCGTTCAAAGATCTTTATGGCGGTCGCTACTACCCTG
CCGCTTCTATGTACACTCTTCCGAACCAACCGAATTGTGTTGTTAAGTTC
AATTTTGGTCCTGATTTTGAGGCATTTCCTGATGATTTTGGTGGGCGCCC
TGTCCCAAGACCTATGATTGAAGTTCCATATCAAAGTTATGATGGCAGAG
TTGAGAACGGTGTGTCCAGTGAGAAGAAACAATAG
|
standard]
MDDASAVSTPPPTTSTVEGGGVGTAPVLTTVNGPELPKPEANHVNGIKEE
AEAAASEELSSEDTSVYGTPQAPDADQISPNLPPETDGDEEEEGEEERPP
KKQKQLSDLPKTEPDEPGMTELPSPANAIADLSQNGKAPATKSSKKSKKK
NKDVWTTTSRKGKKKTKHASNNNHNSKNATNGDTDDKVFVSPVPRFPDKN
DDSPDLKICLSKAYKAEKVELSDDRLTAGSSKGYRMVRATRGVTEGAWYF
EIKVVHLGETGHTRLGWSTDKGDLQAPVGYDANSFGYRDIDGSKVHKALR
EKYGEEGYKEGDVIGFYINLPDGGSYAPDPPRLVWYKGQRYVCAPDARED
PAKVVPGSEISFFRNGICQGVAFKDLYGGRYYPAASMYTLPNQPNCVVKF
NFGPDFEAFPDDFGGRPVPRPMIEVPYQSYDGRVENGVSSEKKQ
|
IPR001870; B302/SPRY domain IPR003877; SPla/RYanodine receptor SPRY IPR018355; SPla/RYanodine receptor subgroup |